ImmunoGen Lead Drug Gets Nod for Accelerated Approval Pathway (Revised)Zacks Investment Research • 12/24/19
ImmunoGen (IMGN) Up 51.7% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/01/19
ImmunoGen Inc (IMGN) CEO Mark Enyedy on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/01/19
ImmunoGen Stretches Its Cash in Q3, Banking on Another Chance for Its Ovarian Cancer DrugThe Motley Fool • 11/01/19
ImmunoGen (IMGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 10/25/19
ImmunoGen (IMGN) Up 18.8% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 09/01/19
Immunogen, Inc. (IMGN) CEO Mark Enyedy on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/02/19
Earnings Preview: ImmunoGen (IMGN) Q2 Earnings Expected to DeclineZacks Investment Research • 07/26/19